7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N,N-diethylheptanamide;(2S)-7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N,2-dimethylheptanamide;7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N-(trifluoromethyl)heptanamide;1-[5-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]pentyl]-N-ethyl-N-methylcyclopropane-1-carboxamide
C164H187F15N28O16 — CID 158837450
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N,N-diethylheptanamide;(2S)-7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N,2-dimethylheptanamide;7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N-(trifluoromethyl)heptanamide;1-[5-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]pentyl]-N-ethyl-N-methylcyclopropane-1-carboxamide
7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N,N-diethylheptanamide;(2S)-7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N,2-dimethylheptanamide;7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N-(trifluoromethyl)heptanamide;1-[5-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]pentyl]-N-ethyl-N-methylcyclopropane-1-carboxamide (PubChem CID 158837450) has the molecular formula C164H187F15N28O16 and a molecular weight of 3091.45 g/mol. Its IUPAC name is 7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N,N-diethylheptanamide;(2S)-7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N,2-dimethylheptanamide;7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N-(trifluoromethyl)heptanamide;1-[5-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]pentyl]-N-ethyl-N-methylcyclopropane-1-carboxamide.
Molecular Properties
| Compound Name | 7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N,N-diethylheptanamide;(2S)-7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N,2-dimethylheptanamide;7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N-(trifluoromethyl)heptanamide;1-[5-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]pentyl]-N-ethyl-N-methylcyclopropane-1-carboxamide |
|---|---|
| PubChem CID | 158837450 |
| Molecular Formula | C164H187F15N28O16 |
| Molecular Weight | 3091.45 g/mol |
| Exact Mass | 3089.44 |
| IUPAC Name | 7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N,N-diethylheptanamide;(2S)-7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N,2-dimethylheptanamide;7-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]-N-ethyl-N-(trifluoromethyl)heptanamide;1-[5-[3-acetyl-5-(2-methylpyrimidin-5-yl)-1-[2-[(1R,3S,5R)-3-[2-[3-methyl-6-(trifluoromethyl)-2-pyridinyl]acetyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]indazol-7-yl]pentyl]-N-ethyl-N-methylcyclopropane-1-carboxamide |
| SMILES | CCN(C(=O)CCCCCCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Cc3nc(C(F)(F)F)ccc3C)c12)C(F)(F)F.CCN(C)C(=O)C1(CCCCCc2cc(-c3cnc(C)nc3)cc3c(C(C)=O)nn(CC(=O)N4[C@@H]5C[C@@H]5C[C@H]4C(=O)Cc4nc(C(F)(F)F)ccc4C)c23)CC1.CCN(C)C(=O)[C@@H](C)CCCCCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Cc3nc(C(F)(F)F)ccc3C)c12.CCN(CC)C(=O)CCCCCCc1cc(-c2cnc(C)nc2)cc2c(C(C)=O)nn(CC(=O)N3[C@@H]4C[C@@H]4C[C@H]3C(=O)Cc3nc(C(F)(F)F)ccc3C)c12 |
| InChI | InChI=1S/C42H48F3N7O4.2C41H48F3N7O4.C40H43F6N7O4/c1-6-50(5)40(56)41(14-15-41)13-9-7-8-10-27-16-28(30-21-46-26(4)47-22-30)17-31-38(25(3)53)49-51(39(27)31)23-37(55)52-33-18-29(33)19-34(52)35(54)20-32-24(2)11-12-36(48-32)42(43,44)45;1-7-49(6)40(55)24(3)11-9-8-10-12-27-15-28(30-20-45-26(5)46-21-30)16-31-38(25(4)52)48-50(39(27)31)22-37(54)51-33-17-29(33)18-34(51)35(53)19-32-23(2)13-14-36(47-32)41(42,43)44;1-6-49(7-2)37(54)13-11-9-8-10-12-27-16-28(30-21-45-26(5)46-22-30)17-31-39(25(4)52)48-50(40(27)31)23-38(55)51-33-18-29(33)19-34(51)35(53)20-32-24(3)14-15-36(47-32)41(42,43)44;1-5-51(40(44,45)46)35(56)11-9-7-6-8-10-25-14-26(28-19-47-24(4)48-20-28)15-29-37(23(3)54)50-52(38(25)29)21-36(57)53-31-16-27(31)17-32(53)33(55)18-30-22(2)12-13-34(49-30)39(41,42)43/h11-12,16-17,21-22,29,33-34H,6-10,13-15,18-20,23H2,1-5H3;13-16,20-21,24,29,33-34H,7-12,17-19,22H2,1-6H3;14-17,21-22,29,33-34H,6-13,18-20,23H2,1-5H3;12-15,19-20,27,31-32H,5-11,16-18,21H2,1-4H3/t29-,33-,34+;24-,29+,33+,34-;29-,33-,34+;27-,31-,32+/m1011/s1 |
| InChIKey | IXUVZLFGCKANOS-AJUCOLSKSA-N |
| XLogP | 27.91 |
| TPSA | 525.00 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 61 |
| Heavy Atoms | 223 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3091.45 |
| LogP ≤ 5 | 27.91 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 36 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'N-C-halo', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158837450 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.